Achieving Unprecedented Efficacy in Biologics
The bispecific antibodies stream at the PEGS Summit will take you from a comprehensive review of these constructs, through the engineering and platform development all the way to preclinical and clinical data. The improved functionality along with newly
developed, innovative solutions for reducing toxicity and limiting side effects is resulting in unprecedented efficacy of bispecific antibodies. Don’t miss this exciting agenda and meet face to face with leaders in the industry.
Conferences and Training Seminars Include:
May 2-3
TS3A: Introduction to Bispecific Antibodies: History, Engineering, and Application
May 3-4
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
May 5-6
Engineering Bispecific Antibodies
Keynote Presentations:
Bispecific Antibodies – Fit for Purpose
Roland Kontermann, PhD, Professor & Deputy Head, Biomedical Engineering, University of Stuttgart
Targeting the Target- Aligning Target and Biologics’ Format Biology to Achieve Desired Outcomes
Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC